Longevity & Prevention

What Your Annual Physical Misses – And Why It Matters

8 min read

Your annual physical is designed to find disease that's already present – not the biological changes that precede it by years. Here's what it's not looking for: ApoB, Lp(a), fasting insulin, thyroid antibodies, sex hormones, and the nutritional markers that standard panels routinely skip.

The annual physical is valuable. It has a purpose, and it fulfills that purpose: it screens for obvious, diagnosable conditions and provides a checkpoint for existing health issues. What it was never designed to do – and what it consistently fails to do – is catch the earlier, subtler shifts that precede those conditions by years or decades.

Understanding what a standard physical includes – and what it doesn’t – is the difference between feeling reassured and actually knowing what’s happening in your body.

What a Standard Physical Actually Includes

A typical annual physical for an adult includes blood pressure measurement, a basic metabolic panel (glucose, kidney function markers, electrolytes), a lipid panel (total cholesterol, LDL, HDL, triglycerides), a complete blood count, and TSH for thyroid screening in women or those at risk. In men over a certain age, PSA may be included.

These tests were designed as screening tools – to catch disease that’s already established and clinically significant. A glucose value flags diabetes. An elevated TSH flags established hypothyroidism. An abnormal CBC suggests a significant blood disorder. They do what they were designed to do.

What they don’t do is reveal the conditions building toward those diagnoses – the processes that will eventually produce those abnormal results, often after a decade or more of silent progression.

Cardiovascular Risk: What the Lipid Panel Misses

The standard lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. These are useful starting points – but they miss a significant proportion of cardiovascular risk.

ApoB – the protein that directly counts atherogenic particles – is consistently shown to predict cardiovascular events better than LDL cholesterol in most populations. Two people can have identical LDL with dramatically different ApoB levels, reflecting very different particle counts and very different cardiovascular risk. ApoB is not on a standard lipid panel.

Lp(a) – a genetically determined lipoprotein that elevates cardiovascular and clotting risk – affects roughly 20% of the population, most of whom don’t know it. Lp(a) doesn’t respond to diet or standard lipid-lowering medications. Testing it once in a lifetime reveals whether someone carries this inherited risk – and allows appropriate monitoring and clinical planning. It’s not on a standard panel.

hs-CRP – the most sensitive available marker of cardiovascular inflammation – independently predicts heart attacks and strokes, even in people with normal cholesterol. The landmark JUPITER trial demonstrated that people with normal LDL but elevated hs-CRP had significantly reduced cardiovascular events with treatment. It’s rarely included in standard panels.

Thyroid: Why TSH Alone Is Insufficient

Thyroid screening in a standard physical measures TSH – a pituitary hormone that signals the thyroid, not the thyroid’s actual output. TSH can remain within reference range while Free T3 and Free T4 – the active thyroid hormones – are declining toward the lower end of normal. People with symptoms of hypothyroidism – fatigue, weight gain, cold sensitivity, brain fog – are frequently told their thyroid is fine when TSH is normal, because Free T3 and Free T4 weren’t measured.

More significantly, thyroid antibodies – TPO antibodies and thyroglobulin antibodies – can be elevated for years or decades before TSH shifts at all, indicating active autoimmune attack on the thyroid tissue. Identifying antibody positivity early allows monitoring and earlier intervention. Standard screening doesn’t check for them.

Metabolic Health: The Gap Between Normal and Optimal

A standard metabolic panel includes fasting glucose – but misses fasting insulin, the marker that reveals insulin resistance before glucose rises. Insulin resistance is present in an estimated one in three American adults and is the upstream driver of prediabetes, type 2 diabetes, cardiovascular disease, fatty liver, and metabolic syndrome. For years before glucose becomes abnormal, the pancreas is working overtime to maintain it – and fasting insulin captures that compensatory effort.

Many people who’ve been told their blood sugar is fine have elevated fasting insulin indicating that their metabolic machinery is under significant strain. They won’t find out from a standard physical.

Hormonal Health: The Invisible Decline

Standard physicals don’t routinely measure sex hormones – testosterone, estradiol, progesterone, or DHEA-S – despite their central role in energy, body composition, mood, cognition, bone health, and cardiovascular function. These hormones change significantly through the decades, and their decline directly affects how people feel and function. But they’re only tested when someone presents with specific complaints that prompt an endocrine evaluation – by which point the changes have typically been significant for years.

IGF-1 – which reflects growth hormone activity and is associated with muscle maintenance, cellular repair, and longevity – is similarly absent from standard screening despite its relevance to healthy aging.

Nutritional Status: What Standard Panels Don’t Check

Standard blood panels don’t routinely include ferritin (the iron storage marker that falls before hemoglobin and affects energy, hair quality, and cognitive function), vitamin D (deficient in over 40% of American adults), vitamin B12 (increasingly deficient in older adults and those on acid blockers), or magnesium (insufficient in a large proportion of Western populations).

These deficiencies are common, consequential, and correctable – but they won’t be identified unless specifically tested for. Many people experience symptoms of these deficiencies for years while being told their blood work is normal, because the relevant markers weren’t checked.

Inflammatory and Longevity Markers

Homocysteine – elevated when B vitamins are insufficient – is independently associated with cardiovascular disease, cognitive decline, and dementia risk. It’s not on a standard panel. It responds readily to B vitamin supplementation when elevated, but only if identified.

ESR and other inflammatory markers beyond basic CRP provide insight into chronic inflammatory burden that accelerates biological aging – similarly absent from standard screening.

What Comprehensive Testing Adds

The gap between what a standard physical measures and what a comprehensive preventive panel measures isn’t a failure of standard care – it’s a reflection of what standard care was designed to do. Standard care screens for established disease in a cost-effective way for population-level health systems. Comprehensive preventive testing is designed for something different: identifying the biological changes that precede disease, in individuals who want to know their complete picture while there’s still time to change it.

The markers that standard care misses are precisely the markers with the highest preventive value – because they’re elevated or abnormal years before the conditions they predict become diagnosable. ApoB and Lp(a) are elevated while arteries are being damaged, not after the heart attack. Fasting insulin is elevated while insulin resistance can still be reversed, not after the diabetes diagnosis. Thyroid antibodies are present while the thyroid is still functioning, not after it’s failed.

The Bottom Line

“Your results came back normal” from an annual physical means your results were normal for the markers that were tested. It doesn’t mean everything worth knowing was checked. The most important information for where you are and where you’re headed isn’t available from a standard blood panel – it requires specifically asking for it.

The annual physical is a useful minimum. For most people who want to actually understand their health trajectory, it’s not nearly enough.


Key Takeaways

  • Annual physicals screen for established disease, not the processes that precede it – a fundamentally different objective from preventive health
  • ApoB and Lp(a) are the cardiovascular markers that standard panels miss – yet they predict heart attack risk more accurately than LDL alone
  • TSH alone misses early thyroid dysfunction and autoimmune thyroid disease – Free T3, Free T4, and antibodies complete the picture
  • Fasting insulin is the metabolic marker standard panels overlook – revealing insulin resistance a decade before glucose rises
  • Sex hormones and IGF-1 are central to how people feel and age – rarely tested in standard care despite their importance
  • Ferritin, vitamin D, B12, and magnesium deficiencies are common and correctable – but invisible without specific testing
  • Comprehensive preventive testing identifies risks during the window when intervention changes outcomes – the decade before the diagnosis is when it matters most
References

Key Sources:

  1. Sniderman AD, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circulation: Cardiovascular Quality and Outcomes. 2011;4(3):337-345. doi:10.1161/CIRCOUTCOMES.110.959247
  2. Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease. JAMA. 2009;302(4):412-423. doi:10.1001/jama.2009.1063
  3. Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine. 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646
  4. Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults. Endocrine Practice. 2012;18(6):988-1028. doi:10.4158/EP12280.GL
  5. Reaven GM. The insulin resistance syndrome. Annual Review of Nutrition. 2005;25:391-406. doi:10.1146/annurev.nutr.24.012003.132155
  6. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutrition Research. 2011;31(1):48-54. doi:10.1016/j.nutres.2010.12.001
  7. Smith AD, et al. Homocysteine and dementia: an international consensus statement. Journal of Alzheimer’s Disease. 2018;62(2):561-570. doi:10.3233/JAD-171042

Choose your region

We offer health testing services in select regions.